Industry Research Reports

Home > Reports > Service & Software > AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-07-24

Pages: 102 Pages

Report ld: 4799099

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI In Drug Development Market Size(US$)

CAGR 2025-2031

56.0%

Market Size,2031

USD 8,369

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 581 million

Market Forecast in 2031(Value)

US$ 8,369 million

CAGR

56.0%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for AI In Drug Development was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.

AI in drug development, also known as AI-assisted drug discovery and development, refers to the application of artificial intelligence (AI) technologies, including machine learning, deep learning, natural language processing, and big data analytics, to accelerate and optimize various stages of drug research and development. This encompasses a wide range of complex and time-consuming processes, from disease target identification, drug molecule design and optimization, high-throughput screening, and preclinical research, to clinical trial design and management, and drug repurposing. By analyzing vast amounts of biomedical data, chemical structure data, genomic data, and clinical trial data, AI can uncover patterns and correlations that are difficult to detect through traditional methods, thereby enhancing the efficiency of drug discovery, reducing research and development costs, shortening time-to-market for new drugs, and improving the overall success rate of drug development.

North American market for AI In Drug Development was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI In Drug Development was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for AI In Drug Development was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of AI In Drug Development include Pfizer, AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Roche, Insilico Medicine, Exscientia, BenevolentAI, Recursion Pharmaceuticals, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for AI In Drug Development, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI In Drug Development by region & country, by Type, and by Application.

The AI In Drug Development market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Drug Development.

MARKET SEGMENTATION

By Company

Pfizer
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Roche
Insilico Medicine
Exscientia
BenevolentAI
Recursion Pharmaceuticals
Atomwise
Isomorphic Labs
XtalPi
Deep Genomics
Relay Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Software
Services

Segment by Application

Biopharmaceuticals
Synthetic Pharmaceuticals
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI In Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI In Drug Development in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI In Drug Development in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI In Drug Development Product Introduction

1.2 Global AI In Drug Development Market Size Forecast (2020-2031)

1.3 AI In Drug Development Market Trends & Drivers

1.3.1 AI In Drug Development Industry Trends

1.3.2 AI In Drug Development Market Drivers & Opportunity

1.3.3 AI In Drug Development Market Challenges

1.3.4 AI In Drug Development Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI In Drug Development Players Revenue Ranking (2024)

2.2 Global AI In Drug Development Revenue by Company (2020-2025)

2.3 Key Companies AI In Drug Development Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI In Drug Development Product Offered

2.5 Key Companies Time to Begin Mass Production of AI In Drug Development

2.6 AI In Drug Development Market Competitive Analysis

2.6.1 AI In Drug Development Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by AI In Drug Development Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Drug Development as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Software

3.1.2 Services

3.2 Global AI In Drug Development Sales Value by Type

3.2.1 Global AI In Drug Development Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global AI In Drug Development Sales Value, by Type (2020-2031)

3.2.3 Global AI In Drug Development Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Biopharmaceuticals

4.1.2 Synthetic Pharmaceuticals

4.1.3 Others

4.2 Global AI In Drug Development Sales Value by Application

4.2.1 Global AI In Drug Development Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global AI In Drug Development Sales Value, by Application (2020-2031)

4.2.3 Global AI In Drug Development Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global AI In Drug Development Sales Value by Region

5.1.1 Global AI In Drug Development Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global AI In Drug Development Sales Value by Region (2020-2025)

5.1.3 Global AI In Drug Development Sales Value by Region (2026-2031)

5.1.4 Global AI In Drug Development Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America AI In Drug Development Sales Value, 2020-2031

5.2.2 North America AI In Drug Development Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe AI In Drug Development Sales Value, 2020-2031

5.3.2 Europe AI In Drug Development Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific AI In Drug Development Sales Value, 2020-2031

5.4.2 Asia Pacific AI In Drug Development Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America AI In Drug Development Sales Value, 2020-2031

5.5.2 South America AI In Drug Development Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI In Drug Development Sales Value, 2020-2031

5.6.2 Middle East & Africa AI In Drug Development Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI In Drug Development Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions AI In Drug Development Sales Value, 2020-2031

6.3 United States

6.3.1 United States AI In Drug Development Sales Value, 2020-2031

6.3.2 United States AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.3.3 United States AI In Drug Development Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe AI In Drug Development Sales Value, 2020-2031

6.4.2 Europe AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe AI In Drug Development Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China AI In Drug Development Sales Value, 2020-2031

6.5.2 China AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.5.3 China AI In Drug Development Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan AI In Drug Development Sales Value, 2020-2031

6.6.2 Japan AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan AI In Drug Development Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea AI In Drug Development Sales Value, 2020-2031

6.7.2 South Korea AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea AI In Drug Development Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia AI In Drug Development Sales Value, 2020-2031

6.8.2 Southeast Asia AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia AI In Drug Development Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India AI In Drug Development Sales Value, 2020-2031

6.9.2 India AI In Drug Development Sales Value by Type (%), 2024 VS 2031

6.9.3 India AI In Drug Development Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Profile

7.1.2 Pfizer Main Business

7.1.3 Pfizer AI In Drug Development Products, Services and Solutions

7.1.4 Pfizer AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.1.5 Pfizer Recent Developments

7.2 AstraZeneca

7.2.1 AstraZeneca Profile

7.2.2 AstraZeneca Main Business

7.2.3 AstraZeneca AI In Drug Development Products, Services and Solutions

7.2.4 AstraZeneca AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.2.5 AstraZeneca Recent Developments

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson Profile

7.3.2 Johnson & Johnson Main Business

7.3.3 Johnson & Johnson AI In Drug Development Products, Services and Solutions

7.3.4 Johnson & Johnson AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.3.5 Johnson & Johnson Recent Developments

7.4 Novartis

7.4.1 Novartis Profile

7.4.2 Novartis Main Business

7.4.3 Novartis AI In Drug Development Products, Services and Solutions

7.4.4 Novartis AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.4.5 Novartis Recent Developments

7.5 Sanofi

7.5.1 Sanofi Profile

7.5.2 Sanofi Main Business

7.5.3 Sanofi AI In Drug Development Products, Services and Solutions

7.5.4 Sanofi AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.5.5 Sanofi Recent Developments

7.6 Roche

7.6.1 Roche Profile

7.6.2 Roche Main Business

7.6.3 Roche AI In Drug Development Products, Services and Solutions

7.6.4 Roche AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.6.5 Roche Recent Developments

7.7 Insilico Medicine

7.7.1 Insilico Medicine Profile

7.7.2 Insilico Medicine Main Business

7.7.3 Insilico Medicine AI In Drug Development Products, Services and Solutions

7.7.4 Insilico Medicine AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.7.5 Insilico Medicine Recent Developments

7.8 Exscientia

7.8.1 Exscientia Profile

7.8.2 Exscientia Main Business

7.8.3 Exscientia AI In Drug Development Products, Services and Solutions

7.8.4 Exscientia AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.8.5 Exscientia Recent Developments

7.9 BenevolentAI

7.9.1 BenevolentAI Profile

7.9.2 BenevolentAI Main Business

7.9.3 BenevolentAI AI In Drug Development Products, Services and Solutions

7.9.4 BenevolentAI AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.9.5 BenevolentAI Recent Developments

7.10 Recursion Pharmaceuticals

7.10.1 Recursion Pharmaceuticals Profile

7.10.2 Recursion Pharmaceuticals Main Business

7.10.3 Recursion Pharmaceuticals AI In Drug Development Products, Services and Solutions

7.10.4 Recursion Pharmaceuticals AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.10.5 Recursion Pharmaceuticals Recent Developments

7.11 Atomwise

7.11.1 Atomwise Profile

7.11.2 Atomwise Main Business

7.11.3 Atomwise AI In Drug Development Products, Services and Solutions

7.11.4 Atomwise AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.11.5 Atomwise Recent Developments

7.12 Isomorphic Labs

7.12.1 Isomorphic Labs Profile

7.12.2 Isomorphic Labs Main Business

7.12.3 Isomorphic Labs AI In Drug Development Products, Services and Solutions

7.12.4 Isomorphic Labs AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.12.5 Isomorphic Labs Recent Developments

7.13 XtalPi

7.13.1 XtalPi Profile

7.13.2 XtalPi Main Business

7.13.3 XtalPi AI In Drug Development Products, Services and Solutions

7.13.4 XtalPi AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.13.5 XtalPi Recent Developments

7.14 Deep Genomics

7.14.1 Deep Genomics Profile

7.14.2 Deep Genomics Main Business

7.14.3 Deep Genomics AI In Drug Development Products, Services and Solutions

7.14.4 Deep Genomics AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.14.5 Deep Genomics Recent Developments

7.15 Relay Therapeutics

7.15.1 Relay Therapeutics Profile

7.15.2 Relay Therapeutics Main Business

7.15.3 Relay Therapeutics AI In Drug Development Products, Services and Solutions

7.15.4 Relay Therapeutics AI In Drug Development Revenue (US$ Million) & (2020-2025)

7.15.5 Relay Therapeutics Recent Developments

8 Industry Chain Analysis

8.1 AI In Drug Development Industrial Chain

8.2 AI In Drug Development Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI In Drug Development Sales Model

8.5.2 Sales Channel

8.5.3 AI In Drug Development Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI In Drug Development Market Trends

Table 2. AI In Drug Development Market Drivers & Opportunity

Table 3. AI In Drug Development Market Challenges

Table 4. AI In Drug Development Market Restraints

Table 5. Global AI In Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global AI In Drug Development Revenue Market Share by Company (2020-2025)

Table 7. Key Companies AI In Drug Development Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI In Drug Development Product Type

Table 9. Key Companies Time to Begin Mass Production of AI In Drug Development

Table 10. Global AI In Drug Development Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Drug Development as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI In Drug Development Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global AI In Drug Development Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global AI In Drug Development Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global AI In Drug Development Sales Market Share in Value by Type (2020-2025)

Table 17. Global AI In Drug Development Sales Market Share in Value by Type (2026-2031)

Table 18. Global AI In Drug Development Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global AI In Drug Development Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global AI In Drug Development Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global AI In Drug Development Sales Market Share in Value by Application (2020-2025)

Table 22. Global AI In Drug Development Sales Market Share in Value by Application (2026-2031)

Table 23. Global AI In Drug Development Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global AI In Drug Development Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global AI In Drug Development Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global AI In Drug Development Sales Value by Region (2020-2025) & (%)

Table 27. Global AI In Drug Development Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions AI In Drug Development Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions AI In Drug Development Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions AI In Drug Development Sales Value, (2026-2031) & (US$ Million)

Table 31. Pfizer Basic Information List

Table 32. Pfizer Description and Business Overview

Table 33. Pfizer AI In Drug Development Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI In Drug Development Business of Pfizer (2020-2025)

Table 35. Pfizer Recent Developments

Table 36. AstraZeneca Basic Information List

Table 37. AstraZeneca Description and Business Overview

Table 38. AstraZeneca AI In Drug Development Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI In Drug Development Business of AstraZeneca (2020-2025)

Table 40. AstraZeneca Recent Developments

Table 41. Johnson & Johnson Basic Information List

Table 42. Johnson & Johnson Description and Business Overview

Table 43. Johnson & Johnson AI In Drug Development Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI In Drug Development Business of Johnson & Johnson (2020-2025)

Table 45. Johnson & Johnson Recent Developments

Table 46. Novartis Basic Information List

Table 47. Novartis Description and Business Overview

Table 48. Novartis AI In Drug Development Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI In Drug Development Business of Novartis (2020-2025)

Table 50. Novartis Recent Developments

Table 51. Sanofi Basic Information List

Table 52. Sanofi Description and Business Overview

Table 53. Sanofi AI In Drug Development Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI In Drug Development Business of Sanofi (2020-2025)

Table 55. Sanofi Recent Developments

Table 56. Roche Basic Information List

Table 57. Roche Description and Business Overview

Table 58. Roche AI In Drug Development Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI In Drug Development Business of Roche (2020-2025)

Table 60. Roche Recent Developments

Table 61. Insilico Medicine Basic Information List

Table 62. Insilico Medicine Description and Business Overview

Table 63. Insilico Medicine AI In Drug Development Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI In Drug Development Business of Insilico Medicine (2020-2025)

Table 65. Insilico Medicine Recent Developments

Table 66. Exscientia Basic Information List

Table 67. Exscientia Description and Business Overview

Table 68. Exscientia AI In Drug Development Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI In Drug Development Business of Exscientia (2020-2025)

Table 70. Exscientia Recent Developments

Table 71. BenevolentAI Basic Information List

Table 72. BenevolentAI Description and Business Overview

Table 73. BenevolentAI AI In Drug Development Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI In Drug Development Business of BenevolentAI (2020-2025)

Table 75. BenevolentAI Recent Developments

Table 76. Recursion Pharmaceuticals Basic Information List

Table 77. Recursion Pharmaceuticals Description and Business Overview

Table 78. Recursion Pharmaceuticals AI In Drug Development Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI In Drug Development Business of Recursion Pharmaceuticals (2020-2025)

Table 80. Recursion Pharmaceuticals Recent Developments

Table 81. Atomwise Basic Information List

Table 82. Atomwise Description and Business Overview

Table 83. Atomwise AI In Drug Development Products, Services and Solutions

Table 84. Revenue (US$ Million) in AI In Drug Development Business of Atomwise (2020-2025)

Table 85. Atomwise Recent Developments

Table 86. Isomorphic Labs Basic Information List

Table 87. Isomorphic Labs Description and Business Overview

Table 88. Isomorphic Labs AI In Drug Development Products, Services and Solutions

Table 89. Revenue (US$ Million) in AI In Drug Development Business of Isomorphic Labs (2020-2025)

Table 90. Isomorphic Labs Recent Developments

Table 91. XtalPi Basic Information List

Table 92. XtalPi Description and Business Overview

Table 93. XtalPi AI In Drug Development Products, Services and Solutions

Table 94. Revenue (US$ Million) in AI In Drug Development Business of XtalPi (2020-2025)

Table 95. XtalPi Recent Developments

Table 96. Deep Genomics Basic Information List

Table 97. Deep Genomics Description and Business Overview

Table 98. Deep Genomics AI In Drug Development Products, Services and Solutions

Table 99. Revenue (US$ Million) in AI In Drug Development Business of Deep Genomics (2020-2025)

Table 100. Deep Genomics Recent Developments

Table 101. Relay Therapeutics Basic Information List

Table 102. Relay Therapeutics Description and Business Overview

Table 103. Relay Therapeutics AI In Drug Development Products, Services and Solutions

Table 104. Revenue (US$ Million) in AI In Drug Development Business of Relay Therapeutics (2020-2025)

Table 105. Relay Therapeutics Recent Developments

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. AI In Drug Development Downstream Customers

Table 109. AI In Drug Development Distributors List

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. AI In Drug Development Product Picture

Figure 2. Global AI In Drug Development Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global AI In Drug Development Sales Value (2020-2031) & (US$ Million)

Figure 4. AI In Drug Development Report Years Considered

Figure 5. Global AI In Drug Development Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI In Drug Development Revenue in 2024

Figure 7. AI In Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Software Picture

Figure 9. Services Picture

Figure 10. Global AI In Drug Development Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global AI In Drug Development Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Biopharmaceuticals

Figure 13. Product Picture of Synthetic Pharmaceuticals

Figure 14. Product Picture of Others

Figure 15. Global AI In Drug Development Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global AI In Drug Development Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America AI In Drug Development Sales Value (2020-2031) & (US$ Million)

Figure 18. North America AI In Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe AI In Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific AI In Drug Development Sales Value by Region (%), 2024 VS 2031

Figure 23. South America AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America AI In Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa AI In Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions AI In Drug Development Sales Value (%), (2020-2031)

Figure 28. United States AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 30. United States AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 34. China AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 35. China AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 36. China AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 46. India AI In Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 47. India AI In Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 48. India AI In Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 49. AI In Drug Development Industrial Chain

Figure 50. AI In Drug Development Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global AI In Drug Development market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global AI In Drug Development market is 56.0% 2025 to 2031.

What was the global market size of AI In Drug Development in 2031? shouQi

What was the global market size of AI In Drug Development in 2025? shouQi

Which companies rank high in the global AI In Drug Development market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI In Drug Development market is projected to grow from US$ 581 million in 2025 to US$ 12590 million by 2032, at a CAGR of 56.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI In Drug Development market size was US$ 581 million in 2025 and is forecast to reach a readjusted size of US$ 12590 million by 2032 with a CAGR of 56.0% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 98
USD 4250.00
(Single User License)
Global AI In Drug Development Market Research Report 2026
The global AI In Drug Development market was valued at US$ 581 million in 2025 and is anticipated to reach US$ 12590 million by 2032, at a CAGR of 56.0% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 112
USD 2900.00
(Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI In Drug Development was estimated to be worth US$ 581 million in 2025 and is projected to reach US$ 12590 million, growing at a CAGR of 56.0% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 108
USD 3950.00
(Single User License)
Global AI In Drug Development Market Research Report 2025
The global market for AI In Drug Development was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 8369 million by 2031, growing at a CAGR of 56.0% during the forecast period.
Published Date: 2025-07-24
Pages: 87
USD 2900.00
(Single User License)
Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI In Drug Development market is projected to grow from US$ 209 million in 2024 to US$ 8369 million by 2031, at a CAGR of 56.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-24
Pages: 138
USD 4900.00
(Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI In Drug Development market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 95
USD 4250.00
(Single User License)

Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI In Drug Development market is projected to grow from US$ 581 million in 2025 to US$ 12590 million by 2032, at a CAGR of 56.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 144
USD 4900.00 (Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI In Drug Development market size was US$ 581 million in 2025 and is forecast to reach a readjusted size of US$ 12590 million by 2032 with a CAGR of 56.0% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 98
USD 4250.00 (Single User License)
Global AI In Drug Development Market Research Report 2026
The global AI In Drug Development market was valued at US$ 581 million in 2025 and is anticipated to reach US$ 12590 million by 2032, at a CAGR of 56.0% from 2026 to 2032.
Published: 2026-03-12
Pages: 112
USD 2900.00 (Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI In Drug Development was estimated to be worth US$ 581 million in 2025 and is projected to reach US$ 12590 million, growing at a CAGR of 56.0% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
USD 3950.00 (Single User License)
Global AI In Drug Development Market Research Report 2025
The global market for AI In Drug Development was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 8369 million by 2031, growing at a CAGR of 56.0% during the forecast period.
Published: 2025-07-24
Pages: 87
USD 2900.00 (Single User License)
Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI In Drug Development market is projected to grow from US$ 209 million in 2024 to US$ 8369 million by 2031, at a CAGR of 56.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-24
Pages: 138
USD 4900.00 (Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI In Drug Development market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 95
USD 4250.00 (Single User License)